Search Results 141-150 of 18890 for B cell lymphomas
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
... B-cell lymphoma, the most common type of non-Hodgkin lymphoma. Understanding who is more likely to have a relapse of lymphoma and why. Finding ways to ...
PHOENIX — Mayo Clinic has created a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell lymphoma, the most common type ...
A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression ...
... B-cell lymphomas. Clinically, four weekly doses of rituximab have proven to be well tolerated and effective in previously untreated as well as relapsed ...
... B-cell lymphoma after CAR T-cell therapy. Blood Adv. 2022 May ... Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas.
Concurrent T-cell/histiocyte-rich large B-cell lymphoma ... T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone ...
... lymphoma who smoked, consumed ... B-cell lymphoma and 93 of 328 of patients with follicular lymphoma, the two most common non-Hodgkin's lymphoma subtypes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.